Cadila Healthcare has received an Establishment Inspection Report (EIR) for its formulations manufacturing facility located at Baddi, India. The US Food and Drug Administration (USFDA) had conducted an inspection at the facility from July 15, 2019 to July 19, 2019. The EIR report stated that the classification of the facility is ‘No Action Indicated (NAI)’.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
